Aducanumab About-face: Experts Weigh In

05:18 EST 7 Nov 2019 | Medscape

There's mixed reaction among Alzheimer experts following the recent announcement by the drug company Biogen that it will pursue regulatory approval of its investigational drug aducanumab after all.
Medscape Medical News

Original Article: Aducanumab About-face: Experts Weigh In


More From BioPortfolio on "Aducanumab About-face: Experts Weigh In"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...